2024.02

On the Feb 9th, Dr. Siwanon Jirawatnotai visited us from Mahidol University, Thailand. He gave us a wonderful lecture entitled 'Capitalizing the cancer dynamic re-wiring for cholangiocarcinoma therapy'. We thank him very much for the fruitful discussion with graduate students.

 2023.11

On the Nov 17th, Dr. MeiChee Tai visited us from Cancer Research Malaysia. She gave us a wonderful lecture entitled 'Polygenic risk scores for prediction of breast cancer risk in Asian populations'. We discussed lots of things. Thank you!

 2023.07

From Silapakorn University, Thailand, we have accepted an exchange student Nichapat, the third lady from the left. She will be at our lab for 12 weeks.

 2023.05

'LASP1, CERS6, and Actin Form a Ternary Complex That Promotes Cancer Cell Migration', was published in Cancers. We sincerely thank collaborators and other persons who supported this project.

The ceramide synthase CERS6 (Ceramide Synthase 6) was overexpressed in non-small cell lung cancer, while elevated expression was associated with increased cell migration, poor prognosis, and lymph node metastasis*1). Previous studies have shown that CERS6 promotes the formation of local structures called lamellipodia, which are essential for cancer cell migration*2), though the detailed mechanism has not been elucidated.

In this study, we identified LASP1 (LIM and SH3 domain protein 1) as a novel binding partner of CERS6 by mass spectrometry analysis. LASP1 has been known to promote the migratory ability of cancer cells through interaction with actin. Interestingly, we found that the interaction between LASP1 and actin is CERS6-dependent. In addition, CERS6 itself also interacts with actin in a LASP1-dependent manner. The ternary complex of CERS6-LASP1-actin revealed a critical role for the cell migration activation mechanism, which is an early step in cancer metastasis. This finding might influence the development of inhibitors in lung cancer metastasis.

*1) Suzuki M et al. CERS6 required for cell migration and metastasis in lung cancer. J Clin Mol Med, 24: 11949-11959, 2020.
*2) Shi H et al. CEBPgamma facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation. Cancer Sci 112:2770-2780, 2021.

 2022.09

'Alanine-serine-cysteine transporter 2 inhibition suppresses prostate cancer cell growth in vitro', a collaboration project with Dr.Masanobu Saruta at Fujita Health University,has been accepted by the JCM.

 2022.09

'Enzyme-labeled antigen method: factors influencing the deterioration of antigen-binding activity of specific antibodies during formalin fixation and paraffin embedding', has been accepted by the Acta Histochemica et Cytochemica. We sincerely thank collaborators and other persons who supported this project.

 2022.05

'Antitumor effect of polyphyllin D on liver metastases of Neuroblastoma', a collaboration project with Drs. Tatsuya Suzuki at Fujita Health University and Seiji Okada at Kumamoto University, has been accepted by the Pediatric Surgery International.

 2022.05

We have new lab members, Siripan Limsirichaikul from Thailand and Tran Quoc Dat from Vietnam.

 2022.04

'Cellular concentrations of plasmalogen species containing a polyunsaturated fatty acid significantly increase under hypoxia in human colorectal cancer, Caco2 cells', a collaboration project with Dr. Keiko Tamiya-Koizumi at Nagoya City University, has been accepted by the Biochemical and Biophysical Research Communications.

 2021.08

'Adipsin-dependent secretion of hepatocyte growth factor regulates the adipocyte-cancer stem cell interaction ', a collaboration project with Dr. Yohei Shimono at Fujita Health University, has been accepted by the Cancers.

 2021.05

'Increased chemosensitivity via BRCA2-independent DNA damage in DSS1- and PCID2-depleted breast carcinomas ', a collaboration project with Dr.Kazuhiko Kuwahara at Fujita Health University Hospital, has been accepted by the Laboratory Investigation.

 2021.04

CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation’ has been accepted by the Cancer Science. We sincerely thank collaborators and other persons who supported this project.

 2021.01

'Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF-1α regulator' a collaboration project with Dr.Takashi Takahashi at Aichi Cancer Center, has been accepted by the Cancer Science.

 2020.12

From Thailand a graduate student Patinya Sawangsri has joined our lab. We sincerely hope covid-19 epidemic calms down soon.

 2020.12

'Inhibition of HSP90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma', a collaboration project with Dr.Takashi Takahashi at Aichi Cancer Center, has been accepted by the Cancer Science.

 2020.09

'Upregulation of S100A10 in metastasized breast cancer stem cells', a collaboration project with Dr. Shimono at Department of Biochemistry of this University, has been accepted by the Cancer Science.

 2020.08

'CERS6 required for cell migration and metastasis in lung cancer', has been accepted by the Journal of Cellular and Molecular Medicine. We sincerely thank collaborators and other persons who supported this project.

 2020.08

For summer holidays, undergraduate students have come and played with a research project. They are performing an immuno-histochemical experiments.

 2020.07

'Vaticanol C, a Phytoalexin, Induces Apoptosis of Leukemia and Cancer Cells by Modulating Expression of Multiple Sphingolipid Metabolic Enzymes', a collaboration project with Dr.Takashi Murate at Chubu University, has been accepted by the Nagoya J Med Sci.

 2020.07

 

 

 

 

Contact information

Phone:+81-562-93-2440

e-mail:motosuzu*fujita-hu.ac.jp(In case of e-mail, please change * to @)

Address:1-98, Dengakugakubo, Kutsukake-cho, Toyoake-city, Aichi, 470-1192, Japan